col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


25 Results       Page 1

 [1] 
Elsevier: Neuromuscular Disorders
  original article Date Title Authors   All Authors
1 [GO] 2025―Oct―04 29PMyological evaluation of patients with post-acute COVID-19 syndrome F. Authier, M. Aoun Sebaiti, S. Souvannanorath, E. Malfatti, E. Itti, G. Severa
2 [GO] 2024―Oct―04 571P Muscular metabolic plasticity in 3D in vitro models against systemic stress factors in ME/CFS and long COVID-19 S. Mughal, F. Andújar-Sánchez, M. Sabater-Arcis, J. Fernández-Costa, J. Ramón-Azcón
3 [GO] 2024―Oct―04 567P A prospective observational study on the effect of intravenous immunoglobulin on small fiber neuropathy after SARS-CoV-2 infection or vaccination J. Shin, J. Lee
4 [GO] 2023―Oct―03 P378 The impact of COVID-19 infection(s), pandemic and associated control measures on patients with Pompe disease M. Theunissen, R. van den Elsen, T. House, B. Crittenden, P. van Doorn, A. van der Ploeg, et al. (+2)
5 [GO] 2023―Oct―03 P111 Quantifying deterioration of motor abilities in ambulant boys with Duchenne muscular dystrophy as a result of COVID-19 lockdown G. Ambegaonkar, J. Anthony, C. De Geode, C. Morse
6 [GO] 2023―Oct―03 P110 A multicenter retrospective study of the impact of COVID-19 on patients with muscular dystrophies T. Matsumura, T. Sato, R. Kitao, M. Funato, Y. Takeshima, H. Arahata, et al. (+5)
7 [GO] 2023―Oct―03 P332 Mitochondrial pathology associated with refractory dermatomyositis after COVID-19 vaccination A. Lauletta, G. Merlonghi, L. Fionda, M. Garibaldi
8 [GO] 2023―Mar―04 266th ENMC International Workshop: Remote delivery of clinical care and validation of remote clinical outcome assessments in neuromuscular disorders: a response to COVID-19 and proactive planning for the future: Amsterdam, The Netherlands, 1-3 April 2022 Lindsay N. Alfano, Meredith K. James, Gita M. Ramdharry, Linda P. Lowes
9 [GO] 2023―Feb―11 Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab Valentina Damato, Gregorio Spagni, Gabriele Monte, Letizia Scandiffio, Paola Cavalcante, Nicole Zampetti, et al. (+6)
10 [GO] 2022―Oct―11 VP.32 Living with Pompe disease in the UK: characterising the patient journey; burden on physical and emotional quality of life; and impact of COVID-19 A. Muir, D. Hughes, L. Bashorum, V. Buxton, N. Johnson, G. McCaughey, et al. (+2)
11 [GO] 2022―Oct―11 VP.12 Covid-19 infections in an adult cohort of Duchenne muscular dystrophy attending the National Hospital for neurology and neurosurgery in London M. Desikan, F. Cruces, A. Pietrusz, R. Quinlivan
12 [GO] 2022―Sep―05 SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature Sithara Ramdas, Ryan Malcolm Hum, Abigail Price, Anna Paul, Jeremy Bland, Georgina Burke, et al. (+7)
13 [GO] 2022―May―11 Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients JI Castiglione, JM Crespo, L Lecchini, FO Silveira, MB Luis, N Cotti, et al. (+8)
14 [GO] 2022―Apr―09 Neuromuscular complications of severe COVID-19 in paediatric patients: medium-term follow-up Daniela Avila-Smirnow, Pamela Céspedes, Felipe Reyes, Jenniffer Angulo, Agustín Cavagnaro, Adriana Wegner
15 [GO] 2022―Feb―05 Early Safety and Tolerability Profile of the BNT162b2 COVID-19 Vaccine in Myasthenia Gravis Itay Lotan, Mark A. Hellmann, Yitzhak Friedman, Hadas Stiebel-Kalish, Israel SteinerMD, Adi Wilf-Yarkoni
16 [GO] 2021―Sep―18 COVID-19 AND NEUROMUSCULAR DISEASES Z. Alhaswani
17 [GO] 2021―Sep―18 COVID-19 AND NEUROMUSCULAR DISEASES S. Delstanche, C. Bernar, L. Buscemi, C. Dubois, M. Duclos, L. Medard, L. Servais
18 [GO] 2021―Sep―18 COVID-19 AND NEUROMUSCULAR DISEASES F. Fortunato, M. Farnè, F. Bianchi, M. Neri, G. Siciliano, V. Sansone, et al. (+7)
19 [GO] 2021―Sep―18 COVID-19 AND NEUROMUSCULAR DISEASES A. Alaamel, R. Şahin, M. Hashal, T. Taşkınoğlu, T. Özel, N. Şimşek Erdem, H. Uysal
20 [GO] 2021―Sep―18 COVID-19 AND NEUROMUSCULAR DISEASES D. Natera-de Benito, S. Aguilera-Albesa, L. Costa-Comellas, M. García-Romero, C. MirandaHerrero, C. Ortez, et al. (+12)
21 [GO] 2021―Sep―18 COVID-19 AND NEUROMUSCULAR DISEASES M. James, L. Alfano, K. Rose, L. Lowes, M. Eagle
22 [GO] 2021―May―07 A Web-based questionnaire survey on the influence of coronavirus disease-19 on the care of patients with muscular dystrophy Tsuyoshi Matsumura, Hiroto Takada, Michio Kobayashi, Takashi Nakajima, Katsuhisa Ogata, Akinori Nakamura, et al. (+16)
23 [GO] 2021―Apr―27 Clinical outcome of SARS-CoV-2 infection in 7 adults with Duchenne Muscular Dystrophy attending a specialist neuromuscular centre Ros Quinlivan, Mahalekshmi Desikan, Francis Cruces, Aleksandra Pietrusz, Konstantinos Savvatis
24 [GO] 2021―Apr―06 COVID-19 in Advanced Duchenne/Becker muscular dystrophy patients Hagit Levine, Dario Prais, Sharon Aharoni, Yoram Nevo, Julia Katz, Eyal Rahmani, et al. (+2)
25 [GO] 2020―Aug―12 Guillain-Barré-Strohl syndrome and COVID-19: case report and literature review Laura Diez-Porras, Enric Vergés, Francisco Gil, Mª José Vidal, Joan Massons, Adrià Arboix
 [1] 

25 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec